Melrose Industries PLC: The Turnaround Kings Who Built an Aerospace Powerhouse

I. Prologue: The UK's M&A Mavericks Turn Pure-Play Aerospace Giant

On the last weekend of May 2026, residents of Garden Grove, California — a dense suburban grid a few miles from Disneyland — were told to leave their homes. A chemical tank at a factory most of them had probably never noticed had suffered what the owner would later describe, in the flat language of a regulatory filing, as a "thermal incident." Roughly 50,000 to 60,000 people were evacuated, according to what the company's finance chief told analysts two months later.²⁰ The plant went dark.

That factory is one of two sites in the world where GKN Aerospace makes the transparencies — the canopies and windows — for the F-35 fighter and for a meaningful share of the passenger cabin windows on commercial aircraft. It generated £136 million of revenue in 2025.¹ It is owned by a London-listed company that, twenty-three years earlier, had been a shell with a market value of £13 million and three men with a plan to buy underperforming factories, fix them, and sell them.³

That is the tension at the heart of Melrose Industries PLC today. The company's founding genius was the ability to walk away — to buy a business, improve it, sell it at the top, hand the money back, and start again. Its current strategy is the opposite. Melrose no longer flips anything. It owns one asset, GKN Aerospace, and it intends to own it forever. And when you own an aerospace supplier forever, you also own the tail risk: the tank that overheats, the powder metal that cracks, the customer whose production line stalls for three years.

The pivot happened in April 2023, when Melrose demerged GKN's automotive, powder metallurgy and hydrogen businesses into a separately listed company, Dowlais Group plc, and kept only the aerospace division.²² Overnight, a UK industrial conglomerate famous for financial engineering became a pure-play aerospace and defence technology supplier — what the industry calls a "Super-Tier 1," sitting between the raw-material houses and the primes. Melrose now describes itself as having design-led content on board 100,000 flights a day, with more than 30 manufacturing sites across 12 countries.²

The financial ambition is explicit and, unusually for a British industrial, quantified five years out. Management has committed to roughly £5 billion of revenue, more than £1.2 billion of adjusted operating profit, and £600 million of free cash flow in 2029.¹⁴ In 2025 the group delivered £3,589 million of revenue, £647 million of adjusted operating profit and £125 million of free cash flow.² The gap between those two sets of numbers is the entire investment debate.

There is a second, subtler tension. Melrose's Engines division earns extraordinary reported margins — 31.9% in 2025 and 33.8% in the first half of 2026 — but a large slice of that profit is not cash.²¹ It is an accounting recognition of aftermarket money that Melrose expects to collect over the coming decades from engine programmes it helped fund. The unbilled contract asset representing that money reached £1,308 million at the end of 2025, up from £922 million a year earlier.² Profit today; cash later. Whether "later" arrives on schedule is the single most important thing an investor in this company has to form a view on.

This is the story of how three dealmakers from a forgotten 1990s conglomerate turned £13 million into a FTSE 100 aerospace group; how they took a 259-year-old British engineering icon by force and provoked a constitutional-scale argument in Westminster about who should be allowed to own Britain's factories; why they then tore up the playbook that made them rich; and what a long-term investor should actually watch to know whether the second act works as well as the first.

A useful frame throughout: Melrose's first two decades were a story about price — buying cheaply, selling dearly. Its next decade is a story about time — whether a company built on three-to-five-year horizons can execute a plan whose payoff arrives in the 2030s.

---

↑ Back to Top

II. The "Buy, Improve, Sell" Era: Founding & Capital Allocation Rigor (2003 – 2017)

In October 2003, a company called Melrose PLC listed on London's Alternative Investment Market with a market capitalisation of £13 million.³ It owned nothing. It had no revenue, no factories, no employees to speak of. What it had were three men who had spent the 1990s running Wassall plc — a leveraged industrial acquirer of the Hanson school — and a proposition that was, in 2003, mildly heretical: that the operational discipline of private equity could be run inside a listed company, with none of private equity's fees and all of its transparency.

Christopher Miller, a chartered accountant who had trained at Coopers & Lybrand and served as an associate director of Hanson plc, joined Wassall's board as chief executive in September 1988. David Roper, also a Coopers-trained accountant who had done time in the corporate finance departments of S.G. Warburg, BZW and Dillon Read, joined the same board the same month, becoming deputy chief executive in 1993. Simon Peckham, a solicitor by training, arrived at Wassall in 1990 and became an executive director in 1999. All three appointments to the Melrose board were dated 29 May 2003.³

The trio's temperament mattered as much as their CVs. They were not engineers and never pretended to be. They were capital allocators who believed most industrial companies were badly run not because the products were bad but because the head office was too big, the incentives pointed at the wrong things, and nobody was measuring cash. Their edge was not proprietary insight into manufacturing. It was a willingness to be ruthless about overhead and patient about price.

The mechanics of the playbook

The Melrose formula was stated with unusual plainness in the company's own annual reports: acquire good manufacturing businesses underperforming their potential, improve them through a mixture of investment, operational change and altered management focus, then choose the right moment to sell — often within three to five years, but flexible — and return the proceeds to shareholders.³

Each verb carried weight. Buy meant targets with real market positions and depressed margins, ideally owned by a private equity seller or an inattentive conglomerate. Improve meant gutting central cost, pushing accountability to divisional managing directors, tying their pay to divisional profit and cash, and — critically — spending money. Melrose was insistent that it invested rather than starved its businesses, a claim it would later need in a political fight. Sell meant exiting at peak operating performance and handing the cash straight back, rather than rolling it into the next deal at whatever price the market demanded.

That last discipline is the part most acquirers fail. Serial acquirers usually reinvest, because reinvesting grows the empire and the fee base. Melrose returned capital and then went back to shareholders to raise fresh equity for the next target. It was a structure that forced the founders to re-earn permission every few years.

The record, deal by deal

The first move came in May 2005: McKechnie and Dynacast, bought together from the private equity group Cinven for £429 million, funded partly by a £230 million equity raise.³ It was a bold first swing for a company that had been a shell eighteen months earlier. The exits validated the model. In May 2007 Melrose sold the McKechnie Aerospace business for £428 million and the PSM business for £30 million, repaying the acquisition debt and returning £220 million to shareholders that August.³ Dynacast was held for six years and sold in June 2011 for US$590 million, an enterprise value of about £370 million against £197 million at entry — quadrupling the equity — with £373.2 million returned to shareholders that August.¹¹³ From a single £429 million purchase, Melrose generated close to £1 billion of cash.³

The second act was FKI plc, acquired in July 2008 for just under £1 billion including debt, on the eve of the financial crisis.³ The timing looked catastrophic and for a while it was; FKI brought lifting and energy businesses — Bridon, Crosby, Brush — into a collapsing global economy. But long holding periods rescued it. Melrose disposed of the pieces over more than a decade; the eventual sale of Brush alone was later disclosed as delivering a 2.6x return on shareholders' initial equity, equivalent to a 29% internal rate of return.¹² The lesson was not that Melrose called the cycle. It was that a low-leverage balance sheet let them wait out a cycle they had called wrong.

Elster Group was the masterpiece. Melrose bought the German gas, electricity and water metering group on 23 August 2012 for an enterprise value of £1.8 billion, financing it with a two-for-one rights issue that raised £1.2 billion and a £1.5 billion five-year banking facility.⁹ Within a year the company reported Elster's operating margin up 1.9 percentage points to 14.1%, and management said it was already a year ahead of its improvement plan.⁹ In July 2015 Melrose agreed to sell Elster to Honeywell for US$5.1 billion. Across the transaction and the associated return, £2,388.5 million was returned to shareholders in 2016 — a distribution larger than the entire equity Melrose had ever raised up to the Elster deal.¹⁰

Then came Nortek, the US maker of air management, security and ergonomics products, acquired on 31 August 2016 for cash consideration of £1,093.1 million, funded by a rights issue of approximately £1,611 million.¹⁰ Nortek was the deal that produced the intellectual break. Melrose sold Nortek Air Management to Madison Industries in June 2021 for £2.62 billion (US$3.625 billion) and returned approximately £730 million to shareholders, equivalent to 15 pence per share — the disposal, plus over £700 million of cash generated during ownership, plus the retained Ergotron and Nortek Control businesses, roughly doubling shareholders' investment.¹²

What the record actually proves

By the time Melrose launched its most famous bid, it was able to tell shareholders that across its three fully exited acquisitions — McKechnie/Dynacast, FKI and Elster — the average return on equity had been 2.7x, that £1 invested in 2003 had become £17.70, and that the average annual return to a shareholder since incorporation had been 21.9%.⁴

Those numbers deserve scrutiny rather than applause. They are self-calculated, they assume participation in every rights issue, and they were published in the middle of a takeover fight, which is not a context that encourages conservatism. But the underlying pattern is verifiable from the disposal announcements themselves, and the pattern is consistent: entry margins in the low teens or below, exit margins mid-to-high teens, and proceeds returned rather than recycled.

The genuine competitive advantage was structural rather than magical. Against private equity firms — KKR, Clayton Dubilier & Rice, Advent — Melrose charged no management fee and no carry beyond a share-based incentive plan, and it could hold assets through a downturn without a fund life forcing a sale. Against permanent-capital industrial compounders — Danaher, Roper Technologies, Illinois Tool Works — Melrose had no obligation to keep buying at rising multiples to sustain growth, because returning capital was an acceptable outcome. It occupied a genuine gap: patient capital with an impatient cost structure.

There is a further point that the returns tables obscure. Melrose was not, in the conventional sense, a leveraged buyer. Each major acquisition was funded predominantly with equity raised from existing shareholders through rights issues — £230 million for McKechnie and Dynacast, £1.2 billion for Elster, roughly £1.6 billion for Nortek — with bank debt as a supporting rather than a leading instrument.³⁹¹⁰ That choice cost the founders returns in good years and saved the company in bad ones. It is the single most underappreciated feature of the model, and it explains why FKI, bought at the worst possible moment in modern financial history, ended as a profitable holding rather than a wipeout.

The weakness was equally structural. The model needed a steady supply of large, badly run, publicly accessible industrial assets. By 2017, after fourteen years of low interest rates had bid up every mediocre manufacturer in the developed world, that supply was thin. Melrose's next target would have to be very large, and it would have to be one nobody else wanted to touch.

---

↑ Back to Top

III. The Siege of GKN: The Hostile Takeover That Shook Westminster (2018)

The Dowlais Ironworks was founded in 1759 in a Welsh valley near Merthyr Tydfil. It cast cannonballs for the Napoleonic wars, became Guest, Keen & Nettlefolds at the turn of the twentieth century, and by 2017 traded as GKN plc: a FTSE 100 engineer with two big businesses — automotive driveline and aerospace — and 259 years of accumulated national symbolism.

It was also, by late 2017, in trouble. Successive charges in its North American aerostructures operation, a leadership transition, and a widening gap between what management promised its divisions could earn and what they actually earned had left the shares in the discount bin. Melrose's own bid documentation made the case with a single, brutal calculation: if GKN had simply achieved the divisional margin targets it had set for itself — 11% to 13% in Aerospace, 8% to 10% in Driveline, 9% to 11% in Powder Metallurgy — its 2017 trading profit would have been roughly £100 million to £300 million higher than the 7.4% actual margin it reported.⁴ GKN was not failing because its markets were bad. It was failing against its own stated ambitions.

The bid

Melrose approached on 12 January 2018. What followed was the most politically charged takeover battle in modern British corporate history. The final offer, put on the table in March, valued GKN at 467 pence per share, or £8.1 billion, with GKN shareholders taking 60% of the combined company plus £1.4 billion in cash — a 43% premium to the undisturbed price. Melrose declared the offer final and set an acceptance deadline of 1:00 p.m. on Thursday 29 March 2018.⁴

GKN's board fought with everything available. It characterised Melrose as short-term asset strippers with no place owning long-cycle aerospace technology. It accelerated a defensive transaction to merge its automotive division with the US drivetrain group Dana Incorporated — a deal Melrose attacked in its own materials as "prejudicial to GKN's UK shareholders."⁴ And in the space of two months, as Melrose's presentation pointed out with some relish, the GKN board articulated several different strategies for the company. For a defence built on the premise of long-term stewardship, that was an awkward look.

Westminster gets involved

What made 2018 different from an ordinary hostile bid was that the British state showed up. GKN supplied components for the F-35 programme and a long list of other defence platforms; it carried a large pension scheme in deficit; and it was, for many MPs, a totem of British industrial capability.

The Business Secretary, Greg Clark, wrote to Simon Peckham on 26 March 2018 — three days before the acceptance deadline — in a letter that reads today like a founding document of modern UK takeover intervention. Clark set out his quasi-judicial power under the Enterprise Act 2002 to refer a bid on national security grounds, then went considerably further. He wrote that he was "mindful of the business model which Melrose operates and its history of acquiring, improving and selling businesses," and that "tensions could arise between this approach and the need for long-term investment and stability."⁵

He then listed the commitments he expected: operating as a UK business, headquartered and listed in the UK; maintaining the UK workforce and engaging with its representatives; continuing to pay UK tax; continuing to invest in R&D programmes such as eDrive and the Wing of the Future; investing in apprenticeships; paying suppliers promptly; and making pension arrangements satisfactory to the trustees and the Pensions Regulator. On defence specifically, Clark wrote that he expected "a commitment to continuity of ownership and strategic investment specific to the defence related business of GKN and to exclude the option of a short-term sale of this business without the consent of the Government."⁵

Melrose complied. As the 2018 annual report later recorded, in April 2018 the company agreed undertakings and consent requirements with the Secretary of State for Business, Energy and Industrial Strategy to preserve the core GKN Aerospace business until April 2023, plus separate restrictions with the Secretary of State for Defence relating to controlled items and government-contractor status. It also gave post-offer undertakings to the Takeover Panel, expiring in April 2023, covering a UK group headquarters, a Main Market listing, a majority of UK-resident directors, preservation of the GKN trademarks and an agreed level of R&D spend.⁶

The vote, and whether it was worth it

Acceptances closed on 29 March 2018 with just over 52% of GKN shareholders backing the offer — a margin of roughly one shareholder in fifty.⁷⁸ Melrose completed the acquisition on 19 April 2018.⁶ Almost immediately, the balance sheet delivered an unpleasant surprise: GKN's net debt on completion was £270 million higher than at the previous year-end, driven largely by £129 million of defence costs and a £182 million working capital outflow.⁶ Fighting a takeover is expensive, and the acquirer pays for it twice.

Did Melrose overpay? On the arithmetic of 2018, it paid a full price for a business earning well below its own targets, funded with a mix of paper and debt, and inherited a large pension deficit and a set of binding constraints on what it could subsequently do. Any reasonable observer at the time would have said the price left little room for error.

But the strategic insight was real and, in hindsight, underappreciated by the market. Buried inside GKN's messy conglomerate structure was an engines business holding long-dated, sole-source positions on the aftermarket economics of several of the most successful jet engine programmes ever launched. Those positions were being valued by the market at automotive-supplier multiples because they sat next to an automotive supplier. Melrose's real bet was not that it could cut GKN's costs. It was that it could eventually separate the good business from the ordinary one — which is exactly what it did five years later, in the same month its undertakings expired.

That timing was not a coincidence, and it tells you something important about how this management team thinks about constraints.

---

↑ Back to Top

IV. The Great Pivot: Demerging Dowlais & Choosing Pure-Play Aerospace (2018 – 2023)

Following the completion of the acquisition on 19 April 2018, Melrose applied its management model to GKN with typical speed: corporate head-office layers were removed, decision-making was decentralized to business units, and executive pay was re-indexed. Melrose's 2018 accounts described divisional incentive plans paying bonuses to key managers based on the increase in value of their respective businesses.⁶

Twenty-three months into ownership, global air travel ground to a halt as COVID-19 hit commercial aviation.

For an acquirer holding a major aerospace supplier near the peak of an industrial cycle, a severe downturn had the potential to undermine the balance sheet. Melrose absorbed the shock through two structural factors: low leverage going into the crisis, and fifteen years of experience stripping overhead without damaging core technical capability. Restructuring was substantial and multi-year: Melrose spent £126 million on restructuring in 2024 alone, falling to £31 million in 2025 as what management called the multi-year transformation programme was finally completed.² Across that window, the group exited underperforming businesses and consolidated its production footprint, ending 2025 with more than 30 sites across 12 countries.² Management also renegotiated legacy fixed-price contracts signed under previous owners that cost inflation and lower production rates had made loss-making.

The epiphany

During that operational restructuring, leadership reached a conclusion that fundamentally altered Melrose's long-standing strategy.

The underlying economic model of commercial aerospace explained why. Developing a major jet engine program requires ten to fifteen years of upfront investment before certification, followed by thirty to forty years of commercial flight. A supplier funding early development operates at a loss for a decade before collecting recurring aftermarket cash flows. Under a traditional three-to-five-year holding period, a seller exits before realizing that lucrative secondary phase—and buyers price their acquisition offers accordingly. The buy-improve-sell model suited assets whose value could be realized within a single operational cycle, but proved poorly matched to long-dated aerospace annuities.

Public markets were also applying divergent valuations to GKN's two main businesses. Automotive suppliers faced valuation compression from electric-vehicle transition costs and OEM pricing pressure, whereas pure-play aerospace suppliers commanded premium multiples due to long-term aftermarket revenue streams. Combining both under one corporate umbrella resulted in a conglomerate discount on both assets.

At its Capital Markets Event on 17 May 2023, Melrose made the strategic break explicit, reporting Aerospace as two divisions — Engines and Structures — for the first time and setting 2025 targets of a 28% Engines operating margin, a 9% Structures margin, roughly £4.0 billion of revenue and £700 million of operating profit, alongside capacity for annual share buybacks of 5% to 10% of the company.¹³ Simon Peckham's framing was that the business was "positioned to fulfil the potential it had at acquisition."¹³ The strategic pivot signaled an intention to retain the core aerospace asset indefinitely.

The split

The demerger completed in April 2023. GKN Automotive, GKN Powder Metallurgy and GKN Hydrogen were separated into Dowlais Group plc, which took its name from the 1759 ironworks and listed on the London Stock Exchange as an independent company.²² Melrose shareholders received shares in both companies, leaving Melrose focused exclusively on GKN Aerospace.

The transaction removed the valuation drag of holding mixed industrial assets with different capital needs, customer bases, and investor profiles. It also eliminated corporate cross-subsidization: single-segment reporting left performance directly exposed to market scrutiny.

Operating earnings expanded over the initial reporting periods. Structures margins moved from 5.1% in 2023 to 7.2% in 2024 to 8.0% in 2025, while Engines went from a 28.9% margin in 2024 to 31.9% in 2025.¹⁴² Group adjusted operating profit rose from £390 million in 2023 to £540 million in 2024 to £647 million in 2025.¹⁴²

However, performance against the targets set at the 2023 Capital Markets Event showed a divergence between operating margins and cash conversion. Melrose targeted roughly £4.0 billion of 2025 revenue and delivered £3,589 million. It targeted a 12% free cash flow margin in 2025 — implying something close to £480 million — and delivered £125 million.¹³² While Engines exceeded its margin target and Structures approached its goal, top-line revenue volume and overall cash generation landed below original targets.

Management cited external aircraft build rates as the primary constraint, noting that airframe manufacturers fell behind public production schedules. On the 2025 results call, chief executive Peter Dilnot put the shortfall at "about 10% lower than we expected because of the supply chain issues," noting that this was "well known and flagged by our customers, including Airbus."¹⁶ The shortfall highlighted the dependence of Tier 1 supplier targets on OEM delivery timelines.

Myth versus reality: the guidance record

A market perception developed that Melrose consistently hits its financial guidance. A review of disclosed metrics shows a clear distinction between internal operational targets and external volume projections.

On metrics directly under management control, execution matched targets. The company committed to completing its multi-year transformation programme by the end of 2025 and did so. It set a target of having 85% of the Airframes defence portfolio sustainably priced by the end of 2025, hit it six months early and finished above 90%.² It guided to £100 million-plus of free cash flow in 2025 and delivered £125 million.¹⁵² Dividend distributions grew by 20% in both 2024 and 2025 while financial leverage was maintained within the company's 1.5x to 2.0x target range.²¹

On targets tied to aircraft build rates and foreign exchange, delivery showed greater variance. The 2023 targets for 2025 revenue and cash conversion margin were both missed. During 2025, management lowered full-year revenue guidance from £3.55–3.70 billion down to £3.425–3.575 billion and adjusted operating profit guidance from £650–690 million down to £620–650 million, attributing the change entirely to sterling strengthening against the dollar, from an assumed US$1.25 to US$1.335.¹⁴¹⁵ The final outcome — £3,589 million of revenue and £647 million of profit — landed above the revised revenue range and near the top of the revised profit range, but below the original one.² Currency translation reduced 2025 revenue by £59 million and operating profit by £19 million.²

The operational evidence demonstrates firm control over cost structures, commercial repricing, and internal restructuring. At the same time, top-line revenues and cash flows remain sensitive to OEM production rates and foreign exchange movements—making margin targets more dependable indicators of operational execution than revenue or cash flow forecasts.

↑ Back to Top

V. Leadership, Governance, & Executive Incentive Structure

On 6 March 2024, Melrose announced that Simon Peckham would step down as chief executive, with Peter Dilnot succeeding him. Co-founder Christopher Miller and long-serving group finance director Geoffrey Martin — appointed back in July 2005 — also departed.³ Within months, the leadership trio that had established the company and overseen its dealmaking era was gone. The transition signaled that Melrose's pure-play aerospace strategy required operational execution rather than transaction engineering.

The new operator

Peter Dilnot presents a sharp contrast to his predecessors. A former helicopter pilot in the British armed forces, Dilnot spent key years at Danaher — the US industrial group renowned for its rigorous lean manufacturing framework — and served as chief executive of waste management firm Renewi plc before joining Melrose. He subsequently led GKN Aerospace and served as Melrose's chief operating officer before assuming the chief executive role.

That background highlights a fundamental shift in executive focus. While founders Miller, Roper, and Peckham were transaction strategists who adapted to operations, Dilnot is an operational specialist. Where the founders emphasized entry and exit multiples, Dilnot focuses on "Brilliant Basics," a lean operating system centered on daily management controls, structured problem-solving, and targeted efficiency initiatives. The metrics reflect this approach: in 2025, the group's total injury rate fell 32% to 4.16, the cost of poor quality dropped 19%, and overall productivity rose three percentage points.² Operational momentum continued into the first half of 2026, with the injury rate falling another 25% year on year and days inventory outstanding declining 5%.¹

While these operational metrics lack the drama of major acquisitions, they represent the key performance indicators required by major OEM clients like Airbus, Boeing, GE Aerospace, Pratt & Whitney, and Rolls-Royce. In aerospace supply chains, quality defects and delivery delays can destroy long-standing commercial partnerships. Initial execution under Dilnot shows progress on plant-level metrics, alongside candid reporting on areas lagging behind. On working capital, the 2025 annual report noted plainly: "we have not yet been successful in reducing our inventory levels across the Group which remain high."² That level of directness provides a clearer metric of management accountability than strategic rhetoric.

The board that was rebuilt around him

The board underwent a restructuring that mirrored the executive transition. Chris Grigg, an experienced FTSE 100 executive and former senior independent director of BAE Systems, assumed the chair role on 30 March 2025. Alison Goligher, previously a non-executive director of Meggitt, joined in May 2025 and became senior independent director in October. Guy Hachey, former president and chief operating officer of Bombardier Aerospace and a former director of Hexcel, joined in August 2025. Mary Petryszyn, who spent a decade at Northrop Grumman as corporate vice president and president of Defence Systems, was appointed on 26 January 2026.²

The strategic background of these directors — spanning BAE Systems, Meggitt, Bombardier, Hexcel, and Northrop Grumman — underscores a clear governance shift. Melrose replaced a board built for dealmaking with one tailored specifically to aerospace and defence oversight, confirming that management does not intend to return to transactional conglomerate acquisitions.

Finance leadership also saw rapid change. Matthew Gregory, who joined as chief financial officer during the 2024 transition, announced in December 2025 that he would retire during 2026. He was succeeded by Ross McCluskey, former group chief financial officer of Intertek plc, who assumed the position on 5 May 2026.² Three financial directors in approximately two years represents significant turnover in the role responsible for cash flow forecasting — landing McCluskey with the Garden Grove plant crisis within a month of taking office.

The pay problem

Executive compensation has historically represented the most contentious element of Melrose's governance record.

Under the 2020 long-term incentive plan, participants were allocated 7.5% of any increase in Melrose's market value over a four-year window. Upon plan maturity, Melrose distributed 28.8 million shares — valued at approximately £176 million — across 21 current and former executives, with the largest awards going to outgoing founders Geoffrey Martin, Simon Peckham, and Christopher Miller. An additional £160 million was remitted to tax authorities, funded by cancelling roughly 25 million shares. Peter Dilnot received just over £1 million in shares, which remain non-transferable for the duration of his employment.¹⁹

Shareholder opposition followed. At the annual general meeting on 30 April 2025, investors rejected the advisory vote on the directors' remuneration report, with 66% of votes cast against the measure.¹⁷ In an update issued on 27 October 2025, Melrose reported that the board chair and remuneration committee chair had engaged with shareholders accounting for nearly 40% of the register. The feedback revealed specific concerns: while shareholders accepted the value-creation plan's payout in principle, they objected to un-prorated annual bonuses for departing executives and the accelerated vesting of nil-cost options.¹⁷

The company subsequently restructured its pay policy. At the general meeting on 29 April 2026, shareholders approved the remuneration report with 97.03% support and the revised remuneration policy with 98.37%.¹⁸ The updated framework replaced the value-share model of prior years with standard public-company metrics based on operating margins, cash generation, and relative shareholder returns.

This remuneration sequence presents two contrasting implications for investors. Critically, the legacy plan delivered substantial payouts just before 2025 free cash flow targets were missed, while the board exercised discretion to accelerate option vesting for departing executives. Conversely, board leadership engaged directly with institutional investors, published detailed explanations of shareholder feedback, and overhauled the pay structure — securing near-unanimous shareholder backing a year later.

What remains unproven is whether executive incentives structured around conventional margin, cash, and return targets generate the same operational drive as a plan offering 7.5% of total equity value creation. That question hinges directly on long-term cash conversion.

↑ Back to Top

VI. Core Business Deep-Dive: Segments, Economics, & Unit Mechanics

Melrose today is GKN Aerospace, and GKN Aerospace is two very different companies wearing one badge. In February 2026, alongside its full-year results, the group renamed the Structures division "Airframes" to better reflect a portfolio that runs well beyond metal-bashing.² The names changed; the economics did not.

In 2025, Engines generated £1,632 million of revenue and £520 million of adjusted operating profit. Airframes generated £1,957 million of revenue and £156 million of profit. Corporate costs took £29 million.² Read that again slowly: the smaller division by revenue produced more than three times the profit of the larger one. That single asymmetry explains almost every strategic decision Melrose has made since the demerger.

Engines: what a risk and revenue sharing partnership actually is

The heart of the Engines business is a structure called a Risk and Revenue Sharing Partnership, and it is worth explaining carefully because it is unintuitive and because it drives both the profit and the controversy.

Imagine a jet engine manufacturer — Pratt & Whitney, GE Aerospace, Rolls-Royce — deciding to develop a new engine. Development will cost billions and take more than a decade before the first one enters service. Rather than fund it alone, the manufacturer invites suppliers to become partners: put up cash and engineering during development, take a defined percentage share of the programme, and in return receive two things. First, the sole-source right to manufacture specific critical components — engine structures, cases, frames — for the life of the programme. Second, and far more valuable, a fixed percentage of the aftermarket revenue that engine generates for the next thirty to forty years, every time an airline sends it to a shop for overhaul.

The analogy that works best is film financing. A partner who invests in the production gets a share of box office and a share of every subsequent licensing stream, for decades, whether or not they do any further work. The catch is that they pay everything up front and collect slowly.

Melrose sits on 19 different engine families as an RRSP partner, though it discloses that six of them will generate 90% of the portfolio's value.² The economically significant positions are on Pratt & Whitney's geared turbofan family — powering the A320neo, A220 and Embraer E2 — GE Aerospace's GEnx on the Boeing 787, and Rolls-Royce's Trent XWB on the A350, plus the legacy CFM56 and V2500 fleets that are now at peak maintenance intensity. On the AirAsia order for 150 A220s announced in May 2026, for example, Melrose disclosed a 4–7% RRSP share on the PW1500G engine that powers the aircraft.¹

Engines is not only RRSPs. Management describes four business models: RRSPs, non-RRSP commercial contracts, engine repairs, and government partnerships.² The repair business has become a genuine growth engine in its own right — it grew 27% in the first half of 2026 — anchored by a new five-year contract with Rolls-Royce covering fan blade repairs on the RB211-535, Trent 700 and Trent 800 at an expanded San Diego facility, multi-year agreements with Pratt & Whitney on GTF component repairs, and a first blisk repair, a technically demanding job on a component where disc and blades are machined as a single piece.¹ The government business holds the type certificate for the RM12 engine powering Sweden's Gripen C/D and is on track to take the same role on the RM16 for the Gripen E.²¹

The accounting judgment investors must understand

Here is where the story gets uncomfortable, and where an independent reading diverges sharply from the headline margin.

Because Melrose's RRSP contracts entitle it to aftermarket revenue decades into the future, accounting standards require it to estimate that future entitlement and recognise a portion of it when it delivers the original equipment. Melrose calls this "variable consideration." In 2025, £324 million of Engines' £520 million of adjusted operating profit was variable consideration — recorded as an increase in an unbilled work-done contract asset, not as cash in the bank.² In the first half of 2026 the figure was £206 million out of £303 million.¹ Guidance for full-year 2026 is £340 million to £380 million.¹

The cumulative effect is visible on the balance sheet: the unbilled work-done asset stood at £1,308 million at the end of 2025.² And it is visible in the cash flow bridge, where the £324 million appears as a straight deduction, turning £647 million of adjusted operating profit into £384 million of operating cash before capital expenditure — and, after capex, pensions, restructuring, powder-metal payments, interest and tax, into £125 million of free cash flow.²

This is not aggressive accounting; it is the required treatment, and Melrose discloses it clearly, including a separate RRSP booklet published alongside its investor materials.²⁴ But it does mean that roughly half of the group's reported operating profit in 2025 was an estimate of money to be received in the 2030s and beyond. Two further disclosures deserve attention: £80 million of 2025 revenue related to performance obligations satisfied in previous years as risk constraints were reassessed, and a further £36 million came from changes in assumptions.² In other words, £116 million of revenue — nearly a fifth of group operating profit — arose from revisiting prior estimates rather than from current-year activity. Those revisions were attributed to operational progress by engine manufacturers giving better visibility on future costs and volumes.² The direction of estimate revisions is something a careful investor should track over time.

Airframes: the long, grinding turnaround

If Engines is an annuity, Airframes is a factory business — and factory businesses live on volume.

The division builds primary wing structures, empennages, landing gear, anti-icing systems, electrical wiring interconnection systems, and aircraft windows and canopies. Over 70% of its content is sole-sourced.² In 2025 it split 65% civil and 35% defence; by the first half of 2026 that had shifted to 63/37 as defence grew 14% while civil declined 1%.²¹

The turnaround has two parts. The first is repricing: systematically renegotiating contracts inherited from previous ownership that had become unprofitable. Melrose set a target of having 85% of the defence portfolio sustainably priced by the end of 2025, hit it six months early, and finished the year above 90%.² That is a concrete, verifiable delivery against a stated target, and it is the strongest single piece of evidence for management's execution credibility.

The second part is volume, and volume has not cooperated. Airframes revenue grew just 3% in 2025 and 4% in the first half of 2026, with civil flat to slightly down.²¹ Margins reached 8.0% for 2025 but slipped to 6.3% in the first half of 2026, or 7.2% excluding the Garden Grove disruption.¹ The medium-term target is low-teens margins by 2029.²

Dilnot's argument on the 2025 results call was that the margin achievement is more impressive than it looks precisely because volume is missing: "we're up at 8% margins despite much, much lower volume. So, as that volume comes in, and it will come in, I mean, the backlog's there, we will see that drop through."¹⁶ The logic is sound — aerostructures plants have high fixed costs, so incremental volume drops through at high incremental margin. The question is whether it arrives. Airbus delivered 793 commercial aircraft in 2025 and in February 2026 targeted A320 production of 70–75 per month by the end of 2027; Boeing grew deliveries 72% to 600 and received FAA approval to build 737 MAX at 42 per month with a goal of 47-plus.² Backlogs across narrowbody and widebody now stretch to nine years.¹ Demand is not the issue. The supply chain is.

The division has also become the vehicle for Melrose's most interesting optionality: a partnership with Anduril UK on uncrewed aerial vehicles, shortlisted for the next phase of the British Army's Project NYX; a clean-sheet UAV demonstrator for Sweden's FMV worth about £12 million, combining structures and propulsion capability; flight-ready structural components for BAE Systems' collaborative combat aircraft prototype; and work with Archer on the Midnight electric aircraft.²¹ None of these are material to 2026 earnings. All of them are cheap calls on where defence procurement is heading. Melrose also holds a joint venture in China that delivered first components on 中国商飞 COMAC's C909 regional jet and began shipping glass windows for the Asian aftermarket.¹

The strategic read is straightforward: Engines is where the value is, Airframes is where the operating leverage is, and the group's 2029 targets require both to work. Neither can be delivered in isolation from the competitive structure of the industry they sit inside.

---

↑ Back to Top

VII. Competitive Landscape, Industry Structure, & Strategic Positioning

Picture the aerospace supply chain as a pyramid. At the apex sit four names that matter: Airbus and Boeing for airframes, and — for large commercial engines — GE Aerospace, Pratt & Whitney and Rolls-Royce, with Safran partnered into GE through CFM International. Below them sits a thin layer of suppliers large enough to design, certify and manufacture entire systems rather than parts to a drawing. That layer is where Melrose lives, and the industry's own term for it is Super-Tier 1.

The distinction is not marketing. A conventional Tier 1 supplier is given a drawing and asked to make the part at a price. A Super-Tier 1 is given a performance requirement and asked to design the solution — which means it owns intellectual property, participates in the programme's economics, and cannot easily be replaced, because replacing it means redesigning the system and recertifying it with the FAA and EASA.

Who Melrose actually competes with

In engine structures and risk-sharing, the closest comparables are European. MTU Aero Engines is the purest read-across: a German group whose business model is built on programme shares in commercial engines plus a large maintenance operation. Safran is both a competitor and, through CFM, effectively a customer. Howmet Aerospace is the American specialist in high-precision engine castings, forgings and fasteners — a different manufacturing niche, but competing for the same wallet share of an engine's bill of materials and, notably, one of the constrained links in the industry's supply chain. Melrose's additive fabrication push is aimed squarely at that constraint.

In airframes and military structures, the landscape has changed more dramatically. Spirit AeroSystems — for two decades the largest independent aerostructures company in the world — ceased to exist as an independent entity on 9 December 2025, when Boeing acquired its Boeing-related commercial and aftermarket operations and Airbus took the sites supporting the A350, A220 and A320 programmes, with Airbus receiving US$439 million as compensation for taking on the loss-making work.²³ Roughly 15,000 employees moved to Boeing and over 4,000 to Airbus.²³

It is tempting to read that as a vindication of Melrose's strategy. The more useful reading is as a warning. Spirit did not fail because aerostructures is a bad business in principle. It failed because it was locked into fixed-price contracts on programmes whose production rates collapsed, could not reprice fast enough, and eventually suffered quality problems that made the primes decide it was safer to own the work than to buy it. Melrose's Airframes division was in precisely the same category of risk in 2018. The difference in outcome so far comes down to two things: Melrose repriced its portfolio aggressively while it still had the leverage to do so, and it sat inside a group whose Engines profits could fund the restructuring. Neither advantage is permanent.

The Spirit resolution also carries a subtler competitive implication. Two of the world's largest airframe programmes are now more vertically integrated than they were. A prime that has just absorbed a struggling supplier has both the capability and the institutional memory to consider absorbing others. Melrose's defence against that is that its content is technically differentiated and often protected by programme-level agreements — but "the customer could decide to make this itself" is a real, if slow-moving, structural risk in build-to-print aerostructures, which is precisely why the company has been exiting that category of work.

There is a useful benchmarking exercise buried in the H1 2026 call. Rothschild & Co Redburn's Joe Orchard observed that Melrose's 15% Engines aftermarket growth looked soft against the 20–30% figures the engine OEMs themselves were reporting, and asked why. Management's answer was twofold: RRSP revenue recognition does not align in timing with what the programme owners report, and Melrose has no exposure to the LEAP aftermarket, which has been the fastest-growing pool in the industry.²⁰ That is a candid and important admission. The CFM LEAP powers the majority of the A320neo fleet and every 737 MAX; not being on it means Melrose's aftermarket ramp is slower and more back-ended than the sector average, and more concentrated in the geared turbofan family, whose own service history has been the industry's most troubled. Diversification across 19 engine families sounds reassuring until you remember that six of them carry 90% of the value.²

TransDigm sits in the landscape as an aspiration rather than a competitor. Its model — acquiring proprietary aftermarket parts with sole-source positions and raising prices — is the gold standard for aerospace aftermarket economics. Melrose's RRSP model reaches a similar destination by a different road: instead of buying installed-base positions in the secondary market, it earns them by funding development. Triumph Group has walked a portfolio-pruning path similar to Melrose's Airframes turnaround, which makes it a useful benchmark for how long such transitions take.

The technology angle

The most interesting thing happening at Melrose is not a contract. It is a manufacturing process.

Additive fabrication — building large metal structures by depositing material with lasers and robots rather than forging or casting them — has been an aerospace promise for fifteen years and an aerospace reality for very few components. Melrose has taken it further than most. Its Fan Case Mount Ring for the PW1500G engine is a two-metre-diameter titanium structure, the largest additive component to achieve FAA certification and, according to the company, the only load-bearing additive engine structure flying today. It reached serial production in 2025, moving from 100 fabricated cases a year to 300, with a 40% reduction in material waste per part.² The group also produced its largest all-additive component to date — a large titanium engine case for the CFM RISE technology demonstrator — using fully automated direct energy deposition that met casting-quality standards.²

Dilnot's commercial framing of this is worth quoting because it explains why customers care. On the 2025 results call he described what gates production across the industry as "forgings and castings," and additive as "a breakthrough technology which can replace some of those structural forgings and castings." He added that it "won't replace the whole £20bn-plus market," but that "the most important thing about it is that it takes some pressure off a very constrained supply environment."¹⁶ Asked directly about margins on the technology, he declined to disclose them, saying only that "it's not a cost-plus model" and that Melrose prices it as an alternative to other methods.¹⁶ Management has committed to a £50 million operating profit contribution from additive in 2029 and confirmed contracts are in place, while declining to name them.¹⁶

That is an honest but unverifiable position. Investors are being asked to underwrite roughly 4% of the 2029 profit target on a technology whose commercial terms are undisclosed. Management has promised an investor teach-in on additive fabrication and defence technology during 2026 — a session worth attending, because it is the cheapest available way to test the claim.¹⁶

Which raises the harder question: how durable is any of this? For that, the frameworks help.

---

↑ Back to Top

VIII. Frameworks Analysis: 7 Powers & Porter's 5 Forces

Strategy frameworks are most useful when they force you to distinguish between an advantage a company has and an advantage a company asserts. Applied honestly to Melrose, they produce a split verdict: the Engines division has genuine, structural power; the Airframes division mostly does not.

Hamilton Helmer's 7 Powers

Cornered resource is the strongest of Melrose's claims, and it applies almost entirely to Engines. An RRSP position on a certified engine programme is a legal entitlement to a share of a revenue stream that cannot be bought, competed for, or replicated once the programme is frozen. The engine manufacturer cannot award it to someone else without redesigning the engine. With 19 engine families in the portfolio and six carrying 90% of the value, Melrose holds a set of contracts that no amount of capital or engineering talent could recreate today.² This is the real moat, and it is genuinely rare.

Switching costs are the second-strongest, and they are physical rather than contractual. Changing the supplier of a flight-critical structure means requalifying the part, requalifying the process, and satisfying the FAA and EASA that the new configuration is safe. On a programme already in service, that is a multi-year, multi-million-dollar exercise with regulatory risk attached and no upside for the customer. Melrose's disclosure that over 70% of Airframes content is sole-sourced is the operative statistic here.² Note, though, that switching costs protect existing positions on existing programmes. They provide no protection at all when a new programme is competed.

Scale economies are real but modest. Aerospace manufacturing is capital-intensive — Melrose spent £94 million on capex in 2025, 0.9 times depreciation, and is guiding higher in 2026 — but Melrose is not the largest player in any of its niches.²¹⁶ Scale here buys credibility with primes more than it buys unit cost.

Process power is where the additive fabrication story lives, alongside decades of accumulated metallurgical, composite and thermal know-how. This is the power most likely to be either dramatically underrated or dramatically overrated, and the evidence is not yet conclusive. Certification of the Fan Case Mount Ring and its move to serial production is hard proof of capability.² Converting capability into pricing power is unproven.

Counter-positioning is weak. Melrose's pure-play focus is a portfolio choice, not a business model its competitors cannot copy. MTU and Safran are equally focused; Howmet is more so.

Network effects are effectively absent. Making titanium engine cases does not get easier because someone else buys them.

Branding exists in an institutional form — a Super-Tier 1's reputation with certification authorities and OEM programme offices is a real asset, and quality escapes destroy it — but it carries no consumer pricing power. The one-third reduction in Melrose's cost of poor quality in the Engines division during 2025 is the kind of metric that maintains this asset.²

Porter's Five Forces

Buyer power is high and getting higher, and this is the force most often understated in bullish accounts of Melrose. Airbus, Boeing, GE, Pratt & Whitney and Rolls-Royce are among the most sophisticated procurement organisations in the world. They set the production rates that determine Melrose's volume, they control the aftermarket relationships that determine Melrose's variable consideration, and — as the Spirit outcome demonstrated — they will vertically integrate if a supplier becomes a problem. The counterweight is that on any given in-service programme, they are locked in. Melrose's exposure to the public dispute between Airbus and Pratt & Whitney over GTF allocation between new-build engines and spares illustrates the dynamic precisely: Melrose is not a party to that argument but is materially affected by its outcome. Dilnot's response on the call — that Pratt "as the overall owner of that programme, is best placed to judge" and that "we think an agreement will be reached" — was diplomatic, and it was also an accurate description of Melrose's lack of control.¹⁶

Threat of new entrants is close to zero. No start-up will become an RRSP partner on a large commercial engine. The combination of certification, capital, insurance, and thirty-year track record requirements makes this the most closed industry in manufacturing.

Supplier power is moderate and currently binding. Melrose has flagged continuing constraints in forgings and castings and shortages of rare earth metal powders used in its repair business.¹ Additive fabrication is partly a strategic answer to this, as is the foundry business acquired in 2025 to bring superalloy castings in-house.¹ That vertical move is a small but telling capital allocation decision: buying supply security rather than growth.

Threat of substitutes is low for the relevant time horizon. Long-haul aviation has no near-term alternative, and gas turbine architecture is not being displaced within this decade. The honest caveat is that substitution risk exists at the component level rather than the market level — a next-generation engine architecture could specify structures Melrose does not make.

Rivalry is episodic rather than continuous. The industry does not compete on price for existing parts; it competes ferociously, once every fifteen to twenty years, for content on the next platform. Melrose is currently partnered on both major next-generation single-aisle engine programmes — CFM RISE and Pratt & Whitney's next-generation GTF — which is the single best forward indicator that its cornered resource will renew.²

The framework verdict is that Melrose's competitive position is genuinely strong where it matters most, structurally weak where it earns the least, and dependent on customers whose own execution it cannot control. That maps directly onto the investment case.

---

↑ Back to Top

IX. Investment Thesis: Bull vs. Bear Case & Key KPIs

On 31 July 2026, Melrose reported first-half results that surpassed operational expectations yet triggered a drop in its stock price. Revenue expanded 10% to £1,873 million, adjusted operating profit rose 16% to £347 million, operating margins widened 50 basis points to 18.5%, free cash flow turned positive at £13 million compared with a £54 million deficit a year earlier, and the interim dividend rose 13% to 2.7 pence.¹ Alongside these gains, management suspended its £175 million share buyback programme.¹

Financial markets rarely penalise sound operational performance; they penalise the uncertainty attached to it. That distinction provides the foundation for evaluating the bull and bear arguments facing the group today.

The case for owning it

The aftermarket is arriving. The core thesis rests on structural timing: engines delivered between 2015 and 2022 are now entering their initial heavy maintenance cycles, and Melrose holds a larger risk-and-revenue sharing partnership (RRSP) stake in these newer platforms than in legacy fleets. First-half 2026 figures reflect this expansion: total Engines aftermarket revenue rose 15%, legacy narrowbody aftermarket work on V2500 and CFM56 engines jumped 27%, and component repair revenue expanded 27%.¹ Supply chain constraints on new aircraft deliveries offer an offset, forcing airlines to extend the service life of existing jets and driving additional maintenance visits.

The operational transformation is finished and the drop-through is real. Transformation expenditure dropped from £126 million in 2024 to £31 million in 2025 as the multi-year footprint consolidation reached completion, helping drive a 240 basis point expansion in operating margins in 2025.² With fixed manufacturing costs restructured for lower baseline build rates, future volume recovery should generate strong operating leverage.

Defence has become a genuine second engine. NATO members raised their baseline defence spending target from 2.0% to 3.5% of GDP in June 2025, while the European Union's ReArm Europe Plan targets €800 billion in funding by 2029. Melrose holds structural content across key platforms including the F-35, Gripen, Apache, Black Hawk, C-130, and Eurofighter.² Airframes defence revenue grew 15% in 2025 and 14% in the first half of 2026.²¹ Management explicitly characterizes defence growth as potential upside rather than a component required to hit its 2029 targets.¹

Capital allocation is disciplined by policy. Executive priorities follow a clear hierarchy: fund internal investment first, expand ordinary dividends second, and distribute excess cash via share buybacks third, while maintaining financial leverage between 1.5x and 2.0x net debt to EBITDA and targeting investment-grade credit metrics over time.¹ Net leverage stood at 1.8x at both December 2025 and June 2026.¹ Full-year ordinary dividend distributions grew 20% in both 2024 and 2025.²

The case against

Cash conversion remains the weak point, and it is the whole argument. In 2025, £647 million of adjusted operating profit yielded just £125 million in free cash flow.² Net interest payments absorbed £115 million over the same period.² On the H1 2026 earnings call, UBS analyst Ian Douglas-Pennant questioned the logic of committing £175 million to share repurchases when full-year 2025 pre-factoring free cash flow stood at £66 million against £130 million in interest obligations, asking whether capital would be better directed toward debt reduction.¹⁶ Management defended the buyback as compliance with established capital allocation policy and a signal of operational confidence—an explanation rooted in corporate policy rather than return metrics.¹⁶

Factoring is a persistent disclosure irritant. Receivables factoring balances reached £396 million at the end of 2025 and £387 million at June 2026, with full-year 2026 free cash flow guidance incorporating an expected £30 million to £50 million net inflow from increased factoring utilization.²¹ Management maintains that factoring simply reflects historical customer arrangements tied to delivery timing, with Chief Executive Peter Dilnot noting that factoring acts as a timing mechanism rather than an operational funding source.¹⁶ Nevertheless, including factoring growth within core free cash flow guidance invites scrutiny regarding underlying cash generation, a point raised by multiple analysts during the results call.¹⁶

The 2029 target now carries visible strain. Management framed its £600 million free cash flow target for 2029 using an exchange rate of US$1.25 to the pound, whereas 2026 planning assumes US$1.37.²¹ Pressed on why the long-term target was not rebased for foreign exchange shifts, management stated that currency headwinds would be counterbalanced by unquantified tailwinds across defence platforms and engine aftermarket demand.¹⁶ While avoiding frequent target revisions maintains administrative consistency, it means the 2029 projections no longer reflect baseline currency assumptions. Achieving the 2029 plan depends heavily on geared turbofan (GTF) engine contracts shifting from cash drags to cash contributors in 2028.¹ Independent verification of this cash inflection point remains inaccessible to external observers.

Garden Grove is an open-ended liability. The initial financial impact of the California plant disruption in the first half of 2026 included a £16 million reduction in revenue, a £9 million drop in operating profit, and £13 million in exceptional costs. Management expects an additional £25 million to £30 million in exceptional costs during the second half, with the facility operating at roughly 50% capacity and incurring a monthly drag of £6 million across revenue, profit, and cash flow.¹ Beyond immediate financial charges, Melrose disclosed that it faces multiple regulatory inquiries, investigations, and legal claims, alongside an ongoing review of its insurance coverage and a potential local compensation program.¹ Chief Financial Officer Matthew Gregory described the buyback pause as temporary rather than a permanent cancellation, while acknowledging that US legal proceedings typically follow extended timelines.²⁰ Rebuilding full operational capacity requires approvals from federal, state, and local agencies, with management offering no fixed timetable for regulatory clearance.²⁰ For a site that manufactures F-35 canopies and was undergoing a capacity doubling project targeted for 2027, the disruption represents a lingering operational risk.²

Geopolitical and demand risk is live. Escapacities in regional conflict between the US and Iran disrupted flight operations in early 2026, driving up aviation fuel costs and leading IATA to revise its 2026 global passenger traffic growth forecast down from 4.9% to 2.1%. Global flight hours fell 3% year-on-year in the second quarter of 2026.¹ Although Melrose reported limited direct impact, the broader thesis for engine aftermarket cash generation depends on sustained flight hours across commercial fleets.

The adjusted-versus-statutory gap is wide and volatile. In the first half of 2026, statutory operating profit landed at £154 million compared with £347 million on an adjusted basis, while statutory diluted earnings per share reached 6.0 pence against 17.7 pence adjusted—a discrepancy driven primarily by unrealized mark-to-market losses on foreign exchange hedges.¹ In the prior-year period, the pattern inverted, with statutory operating profit of £441 million exceeding adjusted operating profit of £310 million.¹⁵ Melrose defines and applies its alternative performance metrics consistently, and derivative movements reflect non-operational accounting adjustments. However, swings of this magnitude highlight the difference between reported numbers and operational reality; for full-year 2024, the group posted a statutory pre-tax loss of £106 million alongside an adjusted operating profit of £438 million.¹⁴ Investors reviewing high-level financial screens without examining underlying filings risk drawing incomplete conclusions.

An activist's angle. A critical view of the business focuses on three recurring issues: the variance between adjusted profits and cash generation, the inclusion of receivables factoring within cash flow guidance, and a history of setting long-term targets that miss on revenue and cash conversion while meeting margin goals. The market derating reflects these concerns, with the share price hovering near 481 pence in early August 2026—giving a market capitalization of £6.0 billion—down from a 52-week peak of 685 pence.²¹ Conversely, operational margin expansion remains documented, leverage metrics remain within corporate targets, and top-line volume shortfalls reflect external aerospace supply chain bottlenecks. Both interpretations draw on verifiable disclosures.

The three things that actually matter

Evaluating Melrose's long-term trajectory requires tracking three primary operational indicators:

Engines adjusted operating margin. Operating margins in Engines expanded from 28.9% in 2024 to 31.9% in 2025 and 33.8% in the first half of 2026, approaching management's medium-term target of mid-to-high 30s.¹⁴²¹ This metric provides a direct measure of high-margin aftermarket mix expansion. Because this margin calculation incorporates unbilled variable consideration estimates, it must be evaluated in tandem with realized cash conversion.

Airframes adjusted operating margin. Margins in Airframes reached 8.0% in 2025 before softening to 6.3% in the first half of 2026, against a 2029 target in the low teens.²¹ This figure reflects operational execution, measuring contract repricing, facility consolidation, and manufacturing drop-through on incremental build volumes.

Group free cash flow after interest and tax. Free cash flow reached £125 million in 2025, was guided to £150 million–£200 million for 2026 prior to the Garden Grove incident, and is targeted at £600 million by 2029.²¹ This represents the definitive test for the investment case. Accounting estimates, contract asset accruals, and long-term targets ultimately depend on whether reported operating profits convert into tangible free cash flow.

↑ Back to Top

X. Strategic Playbook & Investing Lessons

Strip away the specifics, and Melrose's twenty-three-year history offers four transferable lessons, each carrying a distinct strategic trade-off.

1. The hardest capital allocation decision is knowing when to stop selling. Melrose built its reputation on exits. Its most consequential decision was to refuse one. Having spent fifteen years demonstrating that the model's discipline lay in monetising assets at peak operating performance, the founders concluded that GKN Aerospace's Engines business was worth more retained than sold — because its value accrues over a thirty-year aftermarket tail that buyers rarely pay for in advance. While logical for long-cycle aerospace, this choice permanently reduces the company's optionality. An owner that has publicly committed never to sell surrenders its primary negotiating position, meaning shareholders must now be rewarded through operational cash generation rather than transaction exits. The 2023 Capital Markets Event, where the buy-improve-sell framework was set aside, marked that fundamental shift.¹³

2. Long-dated aftermarket economics offer high returns — but require patient capital. The risk-and-revenue sharing model — accepting upfront investment losses in exchange for decades of high-margin, sole-source aftermarket participation — creates strong competitive moats over long horizons. However, revenue recognition and cash flow diverge across that lifecycle, bridged in the interim by accounting estimates. For long-term investors, reported operating margins can flatter underlying economics during the ramp phase and understate them during the harvest phase, making the direction of management's estimate revisions a critical signal of true performance.

3. Conglomerate structures can obscure core assets, and demergers offer a direct remedy. Inside GKN plc, the engines business was valued alongside a cyclical automotive supplier. Separated, it was repriced as a pure-play aerospace franchise. Structure and disclosure unlocked that value rather than operational restructuring alone. When a group's divisions carry divergent capital needs, customer bases, and investor profiles, the resulting conglomerate discount represents a rational market response to bundling — one best resolved through structural separation.

4. Decentralisation cuts costs, but lean operating systems sustain performance. The founders' initial contribution was stripping central overhead and pushing accountability to operating units. Chief Executive Peter Dilnot's focus has been embedding an operating system — Brilliant Basics — designed to make operational improvements continuous. For example, joint kaizen initiatives with GE Aerospace at the Tallassee composites site yielded a 90% reduction in inspection time for GEnx fan cases and established a plan to double weekly output.¹ The distinction is vital for investors: overhead reduction creates a one-off step change, whereas an operating system is designed to drive ongoing productivity gains. Melrose's first two decades relied on step changes; its current strategy depends on continuous operational slope.

A fifth lesson sits uncomfortably alongside the operational record. Melrose's executive incentive structure produced strong alignment alongside substantial shareholder opposition. A compensation plan awarding 7.5% of total value creation aligns management with equity growth, but in a bull market it can generate payouts that public equity markets reject. The company's governance history highlights the necessity of structuring alignment mechanisms with absolute caps alongside performance hurdles.

---

↑ Back to Top

XI. Epilogue & Conference Call Intelligence

The most revealing exchange on Melrose's 2025 results call came when Bank of America analyst Ben Heelan asked whether mergers and acquisitions were back on the agenda — whether the company that once launched an £8.1 billion hostile takeover for GKN might pursue another major deal.

Chief Executive Peter Dilnot offered a definitive rejection of that idea, splitting his response between acquisitions and divestments. On buying, he emphasized that value creation is now organic, noting that while minor technology tuck-ins remain possible — citing a software acquisition to support additive fabrication alongside moves into forgings and castings — "overall, this is an organic growth story." On selling, he added: "in terms of the shape of the portfolio now, we have, over the last few years, exited businesses that are non-core. So, from a disposal point of view, we're done on that basis as well."¹⁶

That position represents a complete departure from Melrose's founding model. The business built on serial transactions now defines execution by the absence of them.

Analyst scrutiny during recent earnings calls has centered on three primary issues, yielding varying levels of detail from management. Regarding the powder metal defect affecting Pratt & Whitney's PW1100G engines, disclosures have been detailed: total cash costs were originally estimated at approximately £200 million, with 2026 outlays lowered from £70 million to £50 million based on partner guidance. A further £25 million remains modeled for 2027, and the chief financial officer instructed analysts to keep their 2027 projections unchanged despite partner estimates of an earlier resolution — noting that Melrose, as a junior partner, experiences financial impacts on a time lag.¹⁶ That guidance provides a concrete and conservative baseline.

On free cash flow, management's explanations have been directionally clear yet structurally less transparent. Leadership outlined three main drivers for reaching the 2029 cash target: earnings growth from rising production, expanding aftermarket returns on newer engine platforms, and the geared turbofan program shifting from a cash drag to a cash generator in 2028. While analysts can model the first two components, management categorized the timing of the engine cash inflection as commercially sensitive.¹⁶ On the first-half 2026 earnings call, executives described this cash trajectory as backend-loaded and "S-shaped."²⁰ As a result, investors must take on trust the single largest financial inflection in the five-year plan.

Regarding the Garden Grove plant disruption, management disclosed known facts while refusing to speculate on open liabilities. In response to questions from JPMorgan and Citi concerning insurance coverage and contingent costs, the chief financial officer confirmed that insurance claims remain under review across multiple policies and reiterated the evacuation scale, while declining to estimate potential compensation payments.²⁰ Pressed on restart timelines, executives acknowledged oversight from multiple federal, state, and local agencies, stating that structured recovery plans are in place while declining to commit to specific reopening dates.²⁰ While cautious given active legal proceedings, this stance leaves second-half 2026 financial guidance framed around operational forecasts that omit the company's most immediate operational risk.

A separate exchange highlighted management's defense of its long-term targets. Morgan Stanley analyst Marie-Ange Riggio asked whether the leadership transition at chief financial officer, alongside slower initial cash progress in 2026, might prompt a review of 2029 targets. Dilnot rejected the premise, disputing the characterization of cash performance and noting that original 2025 free cash flow guidance of £100 million was set under different foreign exchange assumptions and that the group delivered £125 million.¹⁶ This willingness to challenge analyst assumptions directly on earnings calls reflects management's firm stance on its long-term financial trajectory.

By mid-2026, Melrose Industries occupies a dual position. Operating performance across its core divisions has improved consistently since the 2023 demerger, supported by sole-source positions on key engine platforms and strong demand across commercial and defense aerospace markets. At the same time, cash conversion lags reported operating profits, the long-term 2029 financial plan relies on an unverified cash inflection point, and the group faces ongoing operational and legal liabilities from the chemical disruption at its California plant.

Where the founders' era was evaluated by transaction exits, current leadership will be judged by a single line on the balance sheet: free cash flow conversion, published twice a year, over the next four years.

References

1. Melrose Industries PLC — Unaudited Results for the Six Months Ended 30 June 2026 — Melrose Industries, 2026-07-31 ↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩

2. Melrose Industries PLC — Audited Results for the Year Ended 31 December 2025 — Melrose Industries, 2026-02-27 ↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩

3. Melrose PLC Annual Report for the year ended 31 December 2011 — Melrose PLC, 2012 ↩↩↩↩↩↩↩↩↩↩↩

4. Melrose Industries PLC — Final Offer for GKN: Unlocking the Potential — Melrose Industries, 2018-03-19 ↩↩↩↩

5. Letter from Business Secretary Greg Clark to Melrose Industries PLC — Department for Business, Energy & Industrial Strategy, 2018-03-26 ↩↩

6. Melrose Industries PLC Annual Report 2018 — Melrose Industries, 2019-03-07 ↩↩↩↩

7. Melrose Wins Hostile £8.1bn Battle for GKN — Financial Times, 2018-03-29 ↩

8. Melrose Wins $11 Billion Fight for Engineering Icon GKN — Reuters, 2018-03-29 ↩

9. Melrose Industries PLC — Final Results for the year ended 31 December 2012 (Elster acquisition and rights issue) — Investegate, 2013 ↩↩↩

10. Melrose Industries PLC — Final Results for the year ended 31 December 2017 (return of capital and Nortek completion) — Investegate, 2018 ↩↩↩

11. Melrose PLC — Disposal of Dynacast — Investegate, 2011-06-06 ↩

12. Melrose Industries PLC — Air Management Disposal and Return of Capital — Investegate, 2021-06-22 ↩↩

13. Melrose Industries PLC — Capital Markets Event & New 2025 Guidance — Investegate, 2023-05-17 ↩↩↩↩

14. Melrose Industries PLC — Audited Results for the Year Ended 31 December 2024 — Melrose Industries, 2025-03-06 ↩↩↩↩↩↩

15. Melrose Industries PLC — Unaudited Results for the Six Months Ended 30 June 2025 — Melrose Industries, 2025-08-01 ↩↩↩

16. Melrose Industries PLC 2025 Full Year Results — Transcript — Melrose Industries, 2026-02-27 ↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩

17. Results of Annual General Meeting on 30 April 2025 — Update Statement — Melrose Industries, 2025-10-27 ↩↩

18. Melrose Industries PLC — Results of AGM — Investegate, 2026-04-29 ↩

19. UK 'robber baron' company Melrose gives bosses £176m handout — The Guardian, 2024 ↩

20. Earnings call transcript: Melrose H1 2026 profit rises as Garden Grove clouds outlook — Investing.com, 2026-07-31 ↩↩↩↩↩↩↩

21. Melrose Industries PLC (MRO) Live Quote and Filings — London Stock Exchange ↩

22. Dowlais Group plc — Official Corporate Website ↩↩

23. Boeing and Airbus complete acquisition of Spirit AeroSystems — CompositesWorld, 2025-12-09 ↩↩

24. Melrose Industries PLC — Investor Relations Portal ↩